Open Orphan (LON:ORPH) Trading Up 5.3% – Should You Buy?

Shares of Open Orphan Plc (LON:ORPHGet Free Report) were up 5.3% during mid-day trading on Tuesday . The stock traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.13). Approximately 652,639 shares traded hands during mid-day trading, a decline of 58% from the average daily volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).

Open Orphan Stock Up 5.3 %

The stock has a 50-day moving average of GBX 10 and a 200 day moving average of GBX 10. The company has a market capitalization of £67.09 million and a PE ratio of -25.30. The company has a quick ratio of 1.16, a current ratio of 1.19 and a debt-to-equity ratio of 10.88.

Open Orphan Company Profile

(Get Free Report)

Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.

Featured Stories

Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.